ABSTRACT
INTRODUCTION
Some tablet pharmaceutical preparations containing mebhydroline napadisylate as sole active ingredient, are marketed now in Indonesia [1] . Mebhydroline napadisylate in pharmaceutical preparation is not official in any pharmacopoeia and has not been published yet. An analytical reference book, Pharmaceutical Press [2, 3] described column liquid chromatography (LC) methods for the determination of mebhydroline napadisylate and other drugs in the antihistamine preparations. In the present study we suggest a simple selective and validated HPLC method for the determination of mebhydroline napadisylate in tablets.
The aim of this work was to develop a simple, rapid, and validated HPLC method for routine analysis of mebhydroline napadisylate in tablet. 
EXPERIMENTAL SECTION

Material
Procedure
Sample Extraction
Ten tablets were accurately weighed and finely powdered. An amount equivalent to 10.0 mg mebhydroline napadisylate was transferred into 10.0 mL volumetric flask, and dissolved in 5.0 mL mobile phase, ultrasonicated for 5 min and then diluted to 10.0 mL with mobile phase. The solution was filtered using 0.45 m nylon membrane filter, then 2.0 mL of filtrate NOTE was transferred into 10.0 mL volumetric flask and diluted with mobile phase.
Chromatographie Procedure
Chromatography was performed on a reversed phase C-18 column, using a mobile phase of acetonitrile : ammonia 25% (80 : 20 v/v). The mobile phase was filtered by using a 0.45 m nylon membrane filter and degassed in an ultrasonic bath before used. The samples were also filtered using 0.45 m nylon membrane filter. The flow rate was set at 1.0 mL/min and UV detection at 320 nm. The column was allowed to stand for 15 min before analysis was performed. All determinations were performed at ambient temperature 25±5 °C and the injection volume was 20 L.
Methods Validation.
The method was validated for Linearity, detection limit (DL), and accuracy by the method of Funk et al, [4] Hahn-Dienstrop, [5] and Huber [6] . A four point accuracy study (added with 0%, 20%, 40% and 60% of the label claim) was performed on the Interhistin tablet. For commercial preparations, accuracy studies were performed using single-point standard addition methods (40% of label claim). The precision was evaluated by analyzing six different extract aliquots from interhistin tablet according to a modified method of Renger et al [7] .
RESULT AND DISCUSSION
The developed HPLC method was applied to the determination of mebhydroline napadisylate in tablet. To optimize HPLC assay parameters, the mobile phase composition was studied (Table 1) . A satisfactory separation was obtained with a mobile phase of acetonitrile : ammonia 25% (80 : 20 v/v) using C-18 column at ambient temperature. The analysis was carried out by isocratic elution with flow rate 1.0 ml/min and detection at 320 nm. Under this condition, the chromatograms (Fig. 2) showed only two peak of mebhydrolin napadisylate (peak A at R t 3 min and peak B at R t 10.7 min), while other components were not detected or developed in this proposed method.
The basic calibration plot of peak area against amount of analyte was constructed within the range 20-200% of the expected values in the pharmaceutical preparations. Linearity of mebhydroline napadisylatee was achieved from 80 to 400 ppm with line equation Y=-49122.1+1870.8X, The relative process standard deviation (Vxo) and Xp values [8] of mebhydroline napadisylatee were 1.7% and 23.6 ppm, respectively (n=6; sdv=7574.4; r=0.9996). ANOVA regression-test for testing linearity of the regression line showed a significant calculated F-value (4837.6 for p<0.0001). The plots of the basic calibration graphs are not shown. The residuals were distributed at random around the regression line; neither trend nor uni-directional tendency was found. a Each measurement was performed by a one analyst and on different days.
Detection limit was determined by making a linear regression of relatively low concentrations [4] of mebhydroline napadisylate (20 to 140 ppm n=6 Vxo=3.3%; sdv=4052.0; r=0.9981; line equation Y=34424.2+1346.0X). The ANOVA regression-test showed a significant F-value (1054.1 for p<0.0001). By this method, the calculated Xp [4] value was 17.6 ppm; in this case, DL=Xp. [4] According to Carr and Wahlich, [7] the value of quantitative limit (QL) could be estimated as three times the DL-value (52.8ppm) Table 2 demonstrates the high accuracy of the new method as revealed by the percentage of mean recovery data (99.5-102.3%). To prove whether systematic error occurred, a linear regression of the recovery curve of Xf (percentage of label claim of the analyte found by the proposed method) against Xc (nominal percentage of label claim of the analyte after addition with the standard) of the Interhistin TR tablets was constructed. [4] In this case, the recovery curve equation was Xf=4.043 + 0.996Xc. The confidence range data (p=0.05) of the intercept VBaf (4.043 ±54.6) and slope VBbf (0.996±0.218) from the recovery curves did not reveal the accurence of constant or proportionalsystematic errors. [4] All of the values of the repeatability and intermediate precision valuations were less than 2% (Table 3) . These values were also less than the required values as described by Ermer [9] and Indrayanto [10] (2.3%; specification range of 95-105%; basic lower limit 99.%; n=6). The three measurements were performed within one laboratory by different days.
CONCLUSION
The presented work describes validated HPLC methods for the assay of mebhydrolin napadisylate in tablets. The suggested method is simple, selective, and accurate. Therefore, the proposed method is suitable for the routine analysis of products of similar composition in pharmaceutical industrial quality control laboratories.
